- Home
- USEA vs XAIR Comparison
USEA vs XAIR Comparison
Compare USEA & XAIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USEA
- XAIR
- Stock Information
- Founded
- USEA 2004
- XAIR 2011
- Country
- USEA Greece
- XAIR United States
- Employees
- USEA N/A
- XAIR N/A
- Industry
- USEA Marine Transportation
- XAIR Medical/Dental Instruments
- Sector
- USEA Consumer Discretionary
- XAIR Health Care
- Exchange
- USEA Nasdaq
- XAIR Nasdaq
- Market Cap
- USEA 15.6M
- XAIR 17.0M
- IPO Year
- USEA N/A
- XAIR N/A
- Fundamental
- Price
- USEA $1.49
- XAIR $1.76
- Analyst Decision
- USEA
- XAIR Strong Buy
- Analyst Count
- USEA 0
- XAIR 1
- Target Price
- USEA N/A
- XAIR $11.00
- AVG Volume (30 Days)
- USEA 24.0K
- XAIR 1.2M
- Earning Date
- USEA 11-11-2025
- XAIR 11-10-2025
- Dividend Yield
- USEA 2.67%
- XAIR N/A
- EPS Growth
- USEA N/A
- XAIR N/A
- EPS
- USEA N/A
- XAIR N/A
- Revenue
- USEA $42,625,000.00
- XAIR $4,782,000.00
- Revenue This Year
- USEA N/A
- XAIR $261.11
- Revenue Next Year
- USEA N/A
- XAIR $151.82
- P/E Ratio
- USEA N/A
- XAIR N/A
- Revenue Growth
- USEA N/A
- XAIR 168.20
- 52 Week Low
- USEA $1.00
- XAIR $1.64
- 52 Week High
- USEA $2.35
- XAIR $13.52
- Technical
- Relative Strength Index (RSI)
- USEA 31.42
- XAIR 33.05
- Support Level
- USEA $1.50
- XAIR $1.65
- Resistance Level
- USEA $1.63
- XAIR $2.07
- Average True Range (ATR)
- USEA 0.05
- XAIR 0.18
- MACD
- USEA -0.02
- XAIR -0.04
- Stochastic Oscillator
- USEA 18.75
- XAIR 14.46
About USEA United Maritime Corporation
United Maritime Corp is an international shipping company. It is engaged in seaborne transportation services. The group currently operates a fleet of seven dry bulk vessels, comprising three Panamax, two Capesize and two Kamsarmax vessels with an aggregate cargo-carrying capacity of approximately 750,758 dwt.
About XAIR Beyond Air Inc.
Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.